Carisma Therapeutics appointed Eugene Kennedy as Chief Medical Officer. Before joining Carisma, Kennedy served as Chief Medical Officer at Galera Therapeutics. Prior to his time at Galera, Kennedy served as Chief Medical Officer at Innovative Cellular Therapeutics. Previously, he served as Chief Medical Officer at Lumos Pharma. Before Lumos, Kennedy held the role of Chief Medical Officer at NewLink Genetics.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CARM:
- Carisma Therapeutics initiated with a Buy at BTIG
- Carisma Therapeutics price target lowered to $9 from $11 at H.C. Wainwright
- Carisma Therapeutics’ Compliance Hurdle: Navigating Anti-Kickback and Fraud Laws in the Pharmaceutical Landscape
- Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
- Carisma Therapeutics reports Q2 EPS (52c), consensus (55c)